Pfizer’s Global Supply facility in Kalamazoo, Michigan, on December 11, 2020.
Jeff Kowalsky | AFP | Getty Images
Pfizer said Tuesday it expects to sell about $15 billion in coronavirus vaccine doses this year.
The company’s Covid-19 vaccine, which it’s making with German partner BioNTech, was the first approved for emergency use in the U.S. It forecast between $59.4 and $61.4 billion in revenue this year.
This is a developing story. Please check back for updates.